Androgenetic Alopecia Aga clinical trials

Explore recruiting androgenetic alopecia aga clinical trials.

Recruiting androgenetic alopecia aga studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Androgenetic Alopecia Aga trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 6-Month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone (Cortexolone 17α-Propionate) Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-Month Single-Blind Treatment with Clascoterone or Vehicle BID Solution (SCALP 2)

Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Androgenetic Alopecia Aga trials by city

Androgenetic Alopecia Aga in Toronto Androgenetic Alopecia Aga in Vancouver Androgenetic Alopecia Aga in Montreal Androgenetic Alopecia Aga in Calgary Androgenetic Alopecia Aga in Edmonton Androgenetic Alopecia Aga in Ottawa Androgenetic Alopecia Aga in Winnipeg Androgenetic Alopecia Aga in Quebec City Androgenetic Alopecia Aga in Hamilton Androgenetic Alopecia Aga in Kitchener Androgenetic Alopecia Aga in London Androgenetic Alopecia Aga in Halifax Androgenetic Alopecia Aga in New York Androgenetic Alopecia Aga in Los Angeles Androgenetic Alopecia Aga in Chicago Androgenetic Alopecia Aga in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease